| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |